Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials
AUTOR(ES)
Warach, Steven
FONTE
BioMed Central
RESUMO
In light of the slow progress in developing effective therapies for ischemic stroke, magnetic resonance imaging techniques have emerged as new tools in stroke clinical trials. Rapid imaging with magnetic resonance imaging, diffusion weighted imaging, perfusion imaging and angiography are being incorporated into phase II and phase III stroke trials to optimize patient selection based on positive imaging diagnosis of the ischemic pathophysiology specifically related to a drug's mechanism of action and as a direct biomarker of the effect of a treatment's effect on the brain.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=59649Documentos Relacionados
- Magnetic resonance perfusion diffusion mismatch, thrombolysis, and clinical outcome in acute stroke
- Diffusion and Perfusion Magnetic Resonance Imaging: Applications to Functional MRI
- Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date
- Magnetic resonance perfusion imaging in neuro-oncology
- Diffusion-weighted imaging as predictor of acute ischemic stroke etiology
